Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (35 ops.)
Latest filing published 12 Jun 2025 for Incyte Corp.
Filing timeline
BuySaleKatherine A. High
Insider track record
Disclosed buys
1
Disclosed sells
35
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Katherine A. High: trading record in brief
Katherine A. High (board member) discloses dealings in 2 companies, chiefly Spark Therapeutics, Inc. and Incyte Corp. In total, 72 filings cover trades dated from 4 February 2015 to 10 June 2025.
The open-market side counts 1 purchase for €14k alongside 35 sales for €11.4M. Netting one side against the other leaves €11.4M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 15 share grants and 20 option exercises.
The record was last updated on 12 June 2025 with a share grant in Incyte Corp. The last insider purchase was made public on 6 February 2015, 4,278 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Katherine A. High
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations72 total
2,518 shares0Common StockSEC:0001628280-25-031007:0
2,830 shares0Common StockSEC:0000879169-24-000095:0
2,505 shares0Common StockSEC:0001209191-23-037798:0
2,144 shares0Common StockSEC:0001209191-22-037799:0
1,923 shares0Common StockSEC:0001209191-21-036409:0
1,282 shares0Common StockSEC:0001209191-20-032607:0
139 shares0Common StockSEC:0001209191-20-021730:0
278,834 shares@ US$114.5060.6% of flowCommon StockSEC:0000899243-19-029434:0
73,249 shares@ US$3.450.5% of flowCommon StockSEC:0000899243-19-008882:0
31,653 shares@ US$113.256.6% of flowCommon StockSEC:0000899243-19-008882:1
5,840 shares@ US$68.450.7% of flowCommon StockSEC:0000899243-19-008882:2
3 shares@ US$40.440.0% of flowCommon StockSEC:0000899243-19-008882:3
64,160 shares@ US$68.458.1% of flowCommon StockSEC:0000899243-19-008882:4
49,561 shares@ US$113.2610.4% of flowCommon StockSEC:0000899243-19-008882:5
21,247 shares@ US$40.441.6% of flowCommon StockSEC:0000899243-19-008882:6
25,993 shares@ US$113.265.4% of flowCommon StockSEC:0000899243-19-008882:7
15,750 shares@ US$56.171.6% of flowCommon StockSEC:0000899243-19-008882:8
11,184 shares@ US$113.262.3% of flowCommon StockSEC:0000899243-19-008882:9
7,875 shares@ US$50.550.7% of flowCommon StockSEC:0000899243-19-008882:10
5,367 shares@ US$113.261.1% of flowCommon StockSEC:0000899243-19-008882:11
2,250 sharesCommon StockSEC:0001609351-19-000025:0
2,250 sharesCommon StockSEC:0001609351-19-000025:2
808 shares@ US$45.080.1% of flowCommon StockSEC:0001609351-19-000025:1
683 shares@ US$45.080.1% of flowCommon StockSEC:0001609351-19-000025:3
2,250 sharesCommon StockSEC:0001609351-18-000012:0
25 of 72 declarations
